Autopsy report · NCT01028716

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

“The study experienced lower accrual rates after the onset of COVID. Upon review of the collected data it was deemed that an adequate amount of subjects has been enrolled to date to assess study aims.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 11 years 5 months before it stopped.
• 46 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Fred Hutchinson Cancer Center

Sponsor type

University, hospital or other

Conditions

Acute Biphenotypic Leukemia; Acute Erythroid Leukemia in Remission; Acute Leukemia in Remission; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission

Interventions

Cyclophosphamide; Filgrastim; Fludarabine Phosphate; Mycophenolate Mofetil; Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation; Peripheral Blood Stem Cell Transplantation

Participants

46

Sites

1

Countries

United States

Trials that died the same way

• The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
  “Study ended early due to COVID-19” (73% match in meaning)
• Vitamin D Status and Bone Health of Older Adults in Care Facilities
  “COVID-19, study status being reviewed on an ongoing basis.” (71% match in meaning)
• Ivermectin in Adults With Severe COVID-19.
  “Lack of severe COVID-19 cases in the place of study” (69% match in meaning)
• Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
  “rate of inclusion and study affected by covid-19 epidemic” (69% match in meaning)
• Peripheral Nerve Stimulation for Back
  “Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.